Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Healthcare Editor
{A1EF0A44-49EE-467F-964C-F748991F5552}
+19 year(s) experience
Medtech Insight
By Ashley Yeo 14 Feb 2019
The EU Medical Device Regulation is 15 months away from being implemented in full, and a new German survey about its potential impact on the medtech innovation and patient-care landscape makes for sobering reading.
Topic Medtech
In Vivo
By Ashley Yeo 06 Sep 2018
Drug delivery technology specialist Consort Medical has capitalized on device respiratory expertise for 50 years, but a renewed focus on strategic expansion has seen it make an IP play, move into the pharma side and target other delivery formats for global pharma industry customers. Its enhanced capabilities will keep rivals on their toes.
Topic Drug review Drug approval
In Vivo
By Ashley Yeo 22 Aug 2018
The health products industry, methods of care delivery and even the public's expectations for improved tools to prevent, monitor and treat disease have transformed dramatically in the past five years. The changes anticipated over a similar period ahead are potentially even more marked, with business continuity impacts for medtech and pharma concerns, according to Deloitte LLP experts who were on the circuit at health care industry events in Germany and the UK this spring.
Medtech Insight
By Ashley Yeo 22 Aug 2018
Medtech regulatory fees in the Philippines are being increased for the first time since 2001. The country's FDA says the new fees will support quality improvements.
Topic Policy and regulation
In Vivo
By Ashley Yeo 22 Aug 2018
Johnson & Johnson's DePuy Synthes orthopedic business has taken a measured view of digital and robotic capabilities, rather than acquiring assets that perhaps do not fully meet its strategic needs. For the business's global R&D head Euan Thomson, any new technology must augment the group's abilities to drive meaningful outcomes.
Topic Digital Health
In Vivo
By Ashley Yeo 11 May 2018
Value is a concept that is increasingly embraced by providers and payers, as well as medtech manufacturers. Leading providers are organizing around value, changing their models and thereby inviting medtech manufacturers to adapt to the post fee-for-service era. Some, like Medtronic, are at the head of the game.
In Vivo
By Ashley Yeo 08 Apr 2018
The leading medtechs are starting to develop models for providers that show how to implement successful digital strategies, a trend that is serving to put pressure on companies that are yet to make a commitment, says ZS Associates' Pete Masloski.
Topic Digital Health
Medtech Insight
By Ashley Yeo 21 Dec 2017
The Accelerated Access Review strikes most of the right notes, but there is still room for improvement.
Medtech Insight
By Ashley Yeo 08 Dec 2017
The second Asian Medtech Associations Regulatory Networking discussion focused on a range of regional issues.
Medtech Insight
By Ashley Yeo 24 Jul 2017
The pace of Brexit-related work that impacts the UK medtech industry shows no sign of slowing over the summer.
Topic Brexit
Medtech Insight
15 Apr 2019
Medtech Insight
11 Apr 2019
In Vivo
08 Apr 2019
Medtech Insight
01 Apr 2019
In Vivo
01 Apr 2019
In Vivo
25 Mar 2019
Medtech Insight
19 Mar 2019
Medtech Insight
14 Mar 2019
In Vivo
07 Mar 2019
Medtech Insight
06 Mar 2019
In Vivo
04 Mar 2019
Medtech Insight
04 Mar 2019
In Vivo
14 Feb 2019
Medtech Insight
13 Feb 2019
Medtech Insight
12 Feb 2019
